2025

Japan’s biggest drugmaker Takeda Pharmaceutical faces challenges in third-quarter profits Getting to the Bottom Line On Thursday, Takeda Pharmaceutical, one of Japan’s largest pharmaceutical companies, released its third-quarter financial results. Unfortunately, the numbers fell short of what analysts had predicted, causing some concerns within the industry. Restructuring for Success Takeda Pharmaceutical has been undergoing a…

Welcome to the Takeda Third Quarter Earnings Update! Exciting News from Takeda in Japan Today, Takeda announced their earnings results for the third quarter of fiscal year 2024, and the numbers are looking great! The company has seen continued advancement of its Growth & Launch Products, with a impressive double-digit growth of 14.6% at CER….

A Tragic Midair Collision in Washington, DC Introduction Tragedy struck in the skies above Washington, DC, when a regional jet operated by American Airlines collided with a military helicopter. The incident occurred as the plane was on approach to Ronald Reagan Washington National Airport around 9 p.m. The jet collided with a Sikorsky H-60 Black…

French pharmaceutical company Sanofi announces positive fourth-quarter results On Thursday, French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts’ estimates. The company also announced its plans to buy back 5 billion euros ($5.21 billion) in shares this year in an effort to boost investor confidence in its drug pipeline. Sanofi, one of…

CLIQ Digital Reports Preliminary 2024 Results CLIQ Digital, a leading digital entertainment company, has recently announced its preliminary financial results for the year 2024. Despite facing challenges in the fourth quarter, the company managed to achieve positive outcomes in various aspects of its business. Key Highlights of CLIQ Digital’s 2024 Results: – 4Q sales declined…

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 30 January 2025 Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 29 January 2025 Aggregate number of ordinary shares of USD 0.01 each purchased:…